SOPHiA GENETICS SA (SOPH) Earnings Call Analysis
NASDAQ · Healthcare · Health Information Services
Next earnings call: 2026-08-04
(Q2 2026)
— full calendar
Earnings Reports
-
SOPH Q1 2026: Net Dollar Retention Climbs to 117% as Platform Expansion Drives Upsell Momentum
May 05, 2026
-
Sophia Genetics (SOPH) Q4 2025: 31% Clinical Revenue Surge Signals Platform Expansion
March 03, 2026
-
Sophia Genetics (SOPH) Q3 2025: 180% Jump in Large Deal Value Signals Pipeline Inflection
November 04, 2025
-
Sophia Genetics (SOPH) Q2 2025: 35 New Customers Drive 20% Core Clinical Growth, Biopharma Stabilizes
August 05, 2025
-
Sophia Genetics (SOPH) Q1 2025: Adjusted Gross Margin Soars 520 bps as Platform Scale Accelerates
July 07, 2025